Positron emission tomography (PET)

What it is

Positron emission tomography (PET) is an imaging technique that uses a small amount of a radioactive tracer to show the metabolic activity of tissues. In gliomas, PET can reveal how metabolically active a tumor is, helping assess it and distinguish active tumor from treatment-related changes.

Understanding Positron emission tomography (PET)

PET works by detecting a tracer that accumulates in metabolically active tissue. Different tracers can be used: while a common general tracer (a glucose analog) is less ideal for brain tumors (since normal brain is very metabolically active), specialized tracers — particularly amino acid tracers developed for brain tumors — improve the ability to image gliomas. PET can help in several ways: distinguishing tumor from treatment effects (such as radiation changes or pseudoprogression), identifying the most active part of a tumor to target for biopsy, assessing tumor extent, and evaluating possible recurrence. PET is typically used to complement MRI when additional information is needed, rather than as a routine first test. Its findings are interpreted alongside MRI and clinical information. Understanding PET in gliomas clarifies how imaging tumor metabolism adds information.

Why it matters

Understanding PET helps patients and families see how imaging a tumor's metabolic activity adds information — helping distinguish active tumor from treatment effects, target biopsies, and assess recurrence, complementing MRI.